Hospital News and Research

RSS

Cell phones useful and feasible for visualizing leg wounds

Use of cell phones to send images via e-mail to consulting physicians at remote locations appears to be a feasible approach for visualization of chronic leg ulcerations, according to an article in the current issue of Archives of Dermatology.

21 Feb 2005

Antimicrobials improperly used about 50% of the time

Antimicrobial medications intended to prevent surgical site infections are appropriately administered to patients (within one hour before incision) only 55.7 percent of the time, according to a study published in the February issue of Archives of Surgery.

21 Feb 2005

Increased risk of urinary incontinence with hormone therapy

Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.

21 Feb 2005

82 percent of women have at least one factor that puts them at risk for a future heart attack

In the second year of a Northern California-based survey conducted by Sutter Health on women and heart disease, results show that more women are aware of heart attack warning signs and the need to take action quickly.

21 Feb 2005

New compound, AMN107, 20 times more potent than Gleevec for chronic myelogenous leukemia treatment

A laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ultimately be more effective than Gleevec®, the current standard of care.

21 Feb 2005

Cannabis use may increase risk of stroke

Regular users of cannabis could be putting themselves at risk of stroke, while they are still young, indicates a case report, published in the Journal of Neurology Neurosurgery and Psychiatry.

20 Feb 2005

Boys who were taller between birth and 1 year earned more than their shorter peers later in life

Slow growth in the year after birth seems to signal poor economic prospects as an adult, suggests a study of 50 year old men in Archives of Disease in Childhood.

20 Feb 2005

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

20 Feb 2005

As little as one drink per week may harm your baby

Expectant mothers should be advised not to drink alcohol, as this may pose health risks to the foetus, argues an editorial in this week's BMJ.

20 Feb 2005

Antidepressant drugs may be associated with an increased risk of suicidal behaviour

Antidepressant drugs may be associated with an increased risk of suicidal behaviour, particularly in the early stages of treatment, shows new evidence in this week's BMJ.

20 Feb 2005

Ground-breaking trial to test best program for obese children

More than 100 overweight young children from the New South Wales, Illawarra region are being sought to participate in one of the first randomised controlled trials of its kind in Australia that will help determine how best to tackle their obesity problem.

17 Feb 2005

Caution on cosmetic injections administered in non-healthcare settings

Local health departments in Northern Virginia, the District of Columbia and Maryland are investigating an outbreak of serious skin reactions among at least 16 women who have developed the condition after receiving cosmetic injections in October and November 2004.

17 Feb 2005

Are hormone therapy drugs safe?

The history of hormone therapy drugs – once thought of as almost magic pills to keep women healthy, vital and young – shows why it is so important to conduct research studies to identify the risks and benefits of drugs, say researchers from Wake Forest University Baptist Medical Center.

17 Feb 2005

Link between muscle movement and breathing rhythms may shed new light on SIDS and sleep apnea

Between 2,000 and 3,000 infant deaths each year are attributed to Sudden Infant Death Syndrome (SIDS), according to the American Academy of Pediatrics. In addition, approximately 12 million Americans suffer from sleep apnea, a respiratory ailment that can lead to death in some cases.

17 Feb 2005

"Frank is Dead" in 9-year-old cancer patient

Much to the relief of well-wishers across the globe, internationally renowned skull base surgeon Hrayr Shahinian, M.D., of the Skull Base Institute in Los Angeles, has announced that "Frank is Dead."

16 Feb 2005

Private health covering more older Australians

Australian Medical Association President, Dr Bill Glasson, said today that the AMA was encouraged that older Australians are taking up private health insurance in greater numbers.

16 Feb 2005

Clinical trial of newest technology to treat thoracic aortic aneurysms

A clinical trial is underway at the Hospital of the University of Pennsylvania (HUP) to study the safety and effectiveness of an endovascular medical device to treat life-threatening thoracic aortic aneurysms. Ronald Fairman, MD, Chief of Vascular Surgery at HUP, is leading the study at Penn and is one of 35 principal investigators in North America to participate in this landmark trial.

16 Feb 2005

Protein may provide a powerful new therapeutic tool for fighting kidney failure

Kidney failure is a significant risk for patients undergoing cardiopulmonary bypass surgery, radiologic testing, antibiotic therapy or in patients suffering from severe infections. More than 80 percent of patients with postoperative acute renal failure die.

16 Feb 2005

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

A typically innocuous virus found in 90 percent of people worldwide is the key to a new treatment for a cancer particularly common in North Africa and Southeast Asia.

16 Feb 2005

EuroVacc 02 HIV Vaccine trial begins

The European Vaccine Effort against HIV/AIDS, has announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005.

16 Feb 2005